Akzo Nobel N.V. (AKZA)

Basic

  • Market Cap

    €11.84B

  • EV

    €16.17B

  • Shares Out

    170.59M

  • Revenue

    €10.75B

  • Employees

    35,000

Margins

  • Gross

    38.54%

  • EBITDA

    11.24%

  • Operating

    8.81%

  • Pre-Tax

    6.84%

  • Net

    3.81%

  • FCF

    5.32%

Returns (5Yr Avg)

  • ROA

    3.68%

  • ROE

    21.97%

  • ROCE

    8.17%

  • ROIC

    6.51%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    €79.42

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    €62.9

  • Earnings (Dil)

    €2.38

  • FCF

    €3.34

  • Book Value

    €25.74

Growth (CAGR)

  • Rev 3Yr

    7.86%

  • Rev 5Yr

    3.08%

  • Rev 10Yr

    -3.14%

  • Dil EPS 3Yr

    -5.16%

  • Dil EPS 5Yr

    6.69%

  • Dil EPS 10Yr

    -0.83%

  • Rev Fwd 2Yr

    1.39%

  • EBITDA Fwd 2Yr

    18.83%

  • EPS Fwd 2Yr

    38.64%

  • EPS LT Growth Est

    24.78%

Dividends

  • Yield

    —

  • Payout

    82.3%

  • DPS

    €1.98

  • DPS Growth 3Yr

    1.03%

  • DPS Growth 5Yr

    -5.25%

  • DPS Growth 10Yr

    1.96%

  • DPS Growth Fwd 2Yr

    2.4%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

9,256.0

9,276.0

8,530.0

9,587.0

10,846.0

10,745.0

Total Revenues % Chg.

-3.7%

0.2%

-8.0%

12.4%

13.1%

1.0%

Cost of Goods Sold, Total

5,329.0

5,314.0

4,745.0

5,683.0

6,923.0

6,604.0

Gross Profit

3,927.0

3,962.0

3,785.0

3,904.0

3,923.0

4,141.0

Selling General & Admin Expenses, Total

3,044.0

2,833.0

2,579.0

2,610.0

2,939.0

2,976.0

R&D Expenses

264.0

262.0

238.0

230.0

258.0

258.0

Other Operating Expenses

4.0

5.0

5.0

-25.0

—

-40.0

Other Operating Expenses, Total

3,312.0

3,100.0

2,822.0

2,815.0

3,197.0

3,194.0

Operating Income

615.0

862.0

963.0

1,089.0

726.0

947.0

Interest Expense, Total

-95.0

-90.0

-62.0

-74.0

-106.0

-169.0

Interest And Investment Income

16.0

17.0

—

15.0

36.0

55.0

Net Interest Expenses

-79.0

-73.0

-62.0

-59.0

-70.0

-114.0

Income (Loss) On Equity Invest.

20.0

20.0

25.0

26.0

18.0

19.0

Currency Exchange Gains (Loss)

—

-24.0

—

-21.0

-85.0

-85.0

Other Non Operating Income (Expenses)

—

—

-7.0

—

13.0

-26.0

EBT, Excl. Unusual Items

556.0

785.0

919.0

1,035.0

602.0

741.0

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

Asset Writedown

—

—

—

—

—

—

Legal Settlements

—

—

—

70.0

—

—

Other Unusual Items

17.0

—

—

—

—

-6.0

EBT, Incl. Unusual Items

573.0

785.0

919.0

1,105.0

602.0

735.0

Income Tax Expense

118.0

230.0

241.0

246.0

214.0

281.0

Earnings From Continuing Operations

455.0

555.0

678.0

859.0

388.0

454.0

Earnings Of Discontinued Operations

6,274.0

22.0

-7.0

6.0

-10.0

-2.0

Minority Interest

-55.0

-38.0

-41.0

-36.0

-26.0

-43.0

Net Income

6,674.0

539.0

630.0

829.0

352.0

409.0

Net Income to Common Incl Extra Items

6,674.0

539.0

630.0

829.0

352.0

409.0

Net Income to Common Excl. Extra Items

400.0

517.0

637.0

823.0

362.0

411.0

Total Shares Outstanding

227.8

199.6

189.9

178.9

170.4

170.6

Weighted Avg. Shares Outstanding

226.6

213.1

191.4

185.0

174.7

170.8

Weighted Avg. Shares Outstanding Dil

227.5

213.8

192.1

185.7

175.3

171.4

EPS

29.5

2.5

3.3

4.5

2.0

2.4

EPS Diluted

29.3

2.5

3.3

4.5

2.0

2.4

EBITDA

854.0

1,117.0

1,225.0

1,346.0

996.0

1,208.0